Cargando…

Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil

OBJECTIVE: To understand patients’ narratives about the barriers they faced in the diagnosis and treatment of multidrug-resistant tuberculosis, and their consequences in Rio de Janeiro State, Brazil. METHODS: This is a qualitative cross-sectional study with non-probabilistic sampling. A theoretical...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhering, Marcela, Dalcolmo, Margareth, Sarubbi, Vicente, Kritski, Afrânio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Saúde Pública da Universidade de São Paulo 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239425/
https://www.ncbi.nlm.nih.gov/pubmed/35766789
http://dx.doi.org/10.11606/s1518-8787.2022056004154
_version_ 1784737290077077504
author Bhering, Marcela
Dalcolmo, Margareth
Sarubbi, Vicente
Kritski, Afrânio
author_facet Bhering, Marcela
Dalcolmo, Margareth
Sarubbi, Vicente
Kritski, Afrânio
author_sort Bhering, Marcela
collection PubMed
description OBJECTIVE: To understand patients’ narratives about the barriers they faced in the diagnosis and treatment of multidrug-resistant tuberculosis, and their consequences in Rio de Janeiro State, Brazil. METHODS: This is a qualitative cross-sectional study with non-probabilistic sampling. A theoretical saturation criterion was considered for composing the number of interviewees. Semi-structured interviews were conducted from August to December 2019 with 31 patients undergoing treatment for multidrug-resistant tuberculosis at an outpatient referral center in Rio de Janeiro. Data were transcribed and processed with the aid of the NVIVO software. Interviews were evaluated by content analysis, and their themes, cross-referenced with participants’ characterization data. RESULTS: Our main findings were: a) participants show a high proportion of primary drug resistance, b) patients experience delays in the diagnosis and effective treatment of multidrug-resistant tuberculosis ; c) healthcare providers fail to value or seek the diagnosis of drug-resistant tuberculosis, thus beginning the inadequate treatment for drug-susceptible tuberculosis, d) primary health units show low report rates of active case-finding and contact monitoring, and e) patients show poor knowledge about the disease. CONCLUSIONS: We need to improve referral systems, and access to the diagnosis and effective treatment of multidrug-resistant tuberculosis; conduct an active investigation of contacts; intensify the training of healthcare providers, in collaboration with medical and nursing schools, in both public and private systems; and promote campaigns to educate the population on tuberculosis signs and symptoms.
format Online
Article
Text
id pubmed-9239425
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Faculdade de Saúde Pública da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-92394252022-07-01 Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil Bhering, Marcela Dalcolmo, Margareth Sarubbi, Vicente Kritski, Afrânio Rev Saude Publica Original Article OBJECTIVE: To understand patients’ narratives about the barriers they faced in the diagnosis and treatment of multidrug-resistant tuberculosis, and their consequences in Rio de Janeiro State, Brazil. METHODS: This is a qualitative cross-sectional study with non-probabilistic sampling. A theoretical saturation criterion was considered for composing the number of interviewees. Semi-structured interviews were conducted from August to December 2019 with 31 patients undergoing treatment for multidrug-resistant tuberculosis at an outpatient referral center in Rio de Janeiro. Data were transcribed and processed with the aid of the NVIVO software. Interviews were evaluated by content analysis, and their themes, cross-referenced with participants’ characterization data. RESULTS: Our main findings were: a) participants show a high proportion of primary drug resistance, b) patients experience delays in the diagnosis and effective treatment of multidrug-resistant tuberculosis ; c) healthcare providers fail to value or seek the diagnosis of drug-resistant tuberculosis, thus beginning the inadequate treatment for drug-susceptible tuberculosis, d) primary health units show low report rates of active case-finding and contact monitoring, and e) patients show poor knowledge about the disease. CONCLUSIONS: We need to improve referral systems, and access to the diagnosis and effective treatment of multidrug-resistant tuberculosis; conduct an active investigation of contacts; intensify the training of healthcare providers, in collaboration with medical and nursing schools, in both public and private systems; and promote campaigns to educate the population on tuberculosis signs and symptoms. Faculdade de Saúde Pública da Universidade de São Paulo 2022-06-20 /pmc/articles/PMC9239425/ /pubmed/35766789 http://dx.doi.org/10.11606/s1518-8787.2022056004154 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Bhering, Marcela
Dalcolmo, Margareth
Sarubbi, Vicente
Kritski, Afrânio
Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil
title Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil
title_full Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil
title_fullStr Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil
title_full_unstemmed Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil
title_short Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil
title_sort barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in brazil
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239425/
https://www.ncbi.nlm.nih.gov/pubmed/35766789
http://dx.doi.org/10.11606/s1518-8787.2022056004154
work_keys_str_mv AT bheringmarcela barriersfacedbypatientsinthediagnosisofmultidrugresistanttuberculosisinbrazil
AT dalcolmomargareth barriersfacedbypatientsinthediagnosisofmultidrugresistanttuberculosisinbrazil
AT sarubbivicente barriersfacedbypatientsinthediagnosisofmultidrugresistanttuberculosisinbrazil
AT kritskiafranio barriersfacedbypatientsinthediagnosisofmultidrugresistanttuberculosisinbrazil